Weekly Digest – January 2025 Weekly Digest – January 2025 30 Jan 2025: TROPION-Lung12 phase 3 trial initiated evaluating DATROWAY as part of adjuvant regimen for patients with early-stage Non-Small Cell Lung Cancer at high risk of relapse The TROPION-Lung12 […]
Weekly Digest – January 2025 Weekly Digest – January 2025 30 Jan 2025: Tubulis announces first patient dosed in Phase 1/2a trial evaluating ADC TUB-030 in advanced solid tumors TUB-030 entered clinical evaluation with the first patient dosed in the […]
Weekly Digest – January 2025 Weekly Digest – January 2025 29 Jan 2025: Vincerx Pharma and Oqory highlight promising data for Oqory’s TROP2 ADC, OQY-3258 Vincerx Pharma and Oqory highlighted Phase 1a/1b data for OQY-3258 It proposed a merger to advance […]
Weekly Digest – January 2025 Weekly Digest – January 2025 27 Jan 2025: Innate Pharma announces first patient dosed in phase 1 study of its Nectin-4 targeting antibody drug conjugate IPH4502 in selected advanced solid tumors Innate Pharma began a […]
